STAT3 and neoplasm: Moreover, concurrent expression of Oct-4 and pSTAT3 with IL-6 treatment data suggest the IL6-JAK-STAT3-Oct-4 signaling axis exist in CRC cells and contributes to tumor metastasis and invasiveness.